Cipla launched generic of drug Sofosbuvir under the brand name Hepcvir for treating Hepatitis C

The drug will be available in Indian market till the end of March 2015.

Jagranjosh
Mar 26, 2015, 17:52 IST

Cipla Limited on 25 March 2015 launched generic drug of Sofosbuvir under the brand name Hepcvir for treating Hepatitis C.

The drug will be available in Indian market till the end of March 2015. The availability of product in other markets is subject to approvals from the regulatory authorities in the respective countries.

Cipla is one of the seven Indian pharmaceutical companies that have been allowed by US-based Gilead Sciences to manufacture and market generic of drug Sofosbuvir. The non-exclusive license agreement in this regard was signed between Gilead Sciences and Cipla in September 2014.

In third week of March 2015, Dr. Reddy’s Laboratories entered into an agreement with Hetero Drugs Limited to distribute and market generic version of US firm Gilead Sciences’ Hepatitis C drug under the brand Resof.

Sofusbuvir marks a new era of medicines in oral treatment of Hepatitis C, which reduce the need for injectables.

In India alone, around 12-18 million patients are estimated to be infected with Hepatitis C, which is several fold greater than those with HIV/AIDS.

Get here latest daily, weekly and monthly Current Affairs and GK in English and Hindi for UPSC, SSC, Banking, Railway, Defence and exams. Download Jagran Josh Current Affairs App.  Check Board Result 2024 for Class 10 and Class 12 like CBSE Board ResultUP Board ResultBihar Board ResultMP Board ResultRajasthan Board Result and Other States Boards.

Take Weekly Tests on app for exam prep and compete with others. Download Current Affairs and GK app

AndroidIOS

Trending

Trending Categories

Latest Education News